yongrong lai
First Affiliated Hospital of Guangxi Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name yongrong lai as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:49 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06685536 · A Long-term Follow-up Study in Participants Who Received CS-101CorrectSequence Therapeutics Co., Ltd · enrolling by invitation · Beta-Thalassemia · principal investigator
- Ph1NCT06655662 · Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.Shenzhen Hemogen · recruiting · Β-thalassemia · principal investigator
- Early Ph1NCT06565026 · CS-206 in Patients With Sickle Cell DiseaseCorrectSequence Therapeutics Co., Ltd · recruiting · Sickle Cell Disease · principal investigator
- Early Ph1NCT06328764 · CS-101 in Patients With β-thalassemiaCorrectSequence Therapeutics Co., Ltd · enrolling by invitation · Beta-Thalassemia · principal investigator
- N/ANCT06300723 · Clinical Study of BRL-101 in Severe SCDBioray Laboratories · unknown · Sickle Cell Disease · study chair
- Early Ph1NCT06024876 · A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemiaCorrectSequence Therapeutics Co., Ltd · completed · Beta-Thalassemia · principal investigator
- Ph4NCT04009525 · Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical StudyFirst Affiliated Hospital of Guangxi Medical University · completed · Thalassemia Major · principal investigator
- Ph4NCT03171831 · Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorFirst Affiliated Hospital of Guangxi Medical University · unknown · Thalassemia Major · principal investigator
- Ph4NCT02342145 · Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia MajorZhongming Zhang · completed · Beta-Thalassemia Major, Graft-versus-host Disease (GVHD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:49 UTC. The ranking covers the 200 most relevant of 280 PubMed records, and a shared surname and initials can bring in a namesake. All 280 on PubMed
- 384 citationsRCR 15.9
- A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients.Int J Radiat Oncol Biol Phys · 2002143 citationsRCR 3.6
- 133 citationsRCR 3.4
- Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients.Nephron · 1995113 citationsRCR 4.0
- 105 citationsRCR 38.4
- 99 citationsRCR 3.4
- A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.J Hematol Oncol · 201891 citationsRCR 2.6
- Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.J Gastroenterol Hepatol · 200671 citationsRCR 1.9
- 64 citationsRCR 1.8
- Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion.Gut Microbes · 202463 citationsRCR 8.7